BioAtla, Inc. (NASDAQ:BCAB) Q4 2023 Earnings Call Transcript
Operator: Greetings and welcome to the BioAtla Fourth Quarter and Full Year 2023 Earnings Call. At this time, all participants are in a listen-only mode.
Bioatla Inc. (BCAB)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Soleus Capital Guy Levy | 4,065,197 | $10,000,385 | -7% | 1.1% |
| 2. | Tang Capital Management Kevin C. Tang | 2,524,076 | $6,209,227 | -34% | 0.57% |
| 3. | Cormorant Asset Management Bihua Chen | 1,181,115 | $2,905,543 | 0.13% | |
| 4. | Sectoral Asset Management Jerome Pfund And Michael Sjostrom | 706,062 | $1,736,913 | 0.74% | |
| 5. | Adage Capital Management Phill Gross And Robert Atchinson | 600,000 | $1,476,000 | -67% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.35 | 4,000 | Director | 19,125 | 2023-03-28 | Filing | |
| $2.33 | 4,000 | Director | 15,125 | 2023-12-26 | Filing | |
| $2.14 | 50,000 | Large Shareholder, Officer, Director | 1,439,283 | 2023-12-20 | Filing | |
| $2.05 | 20,000 | Director | 38,459 | 2023-12-19 | Filing | |
| $2.04 | 7,495 | Officer | 115,659 | 2023-12-19 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $22.47 | 29 | Officer | 134,469 | 2021-12-02 | Filing | |
| $21.74 | 1,405 | Officer | 134,498 | 2021-12-02 | Filing | |
| $24.22 | 880 | Officer | 135,903 | 2021-12-01 | Filing | |
| $23.27 | 4,034 | Officer | 136,783 | 2021-12-01 | Filing | |
| $22.19 | 2,332 | Officer | 140,817 | 2021-12-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,884,014 | $7,094,674 | 0% | |
| 2. | 2,081,370 | $5,120,171 | 0% | |
| 3. | 1,913,115 | $4,706,263 | 0% | |
| 4. | 1,125,203 | $2,768,000 | 0% | |
| 5. | 904,080 | $2,224,265 | 0% |
News See All
BioAtla, Inc. (NASDAQ:BCAB) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the BioAtla Third Quarter 2023 Earnings Call. At this time, all lines are in a listen-only mode.
BioAtla, Inc. (NASDAQ:BCAB) Q2 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the BioAtla Second Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
BioAtla, Inc. (NASDAQ:BCAB) Q1 2023 Earnings Call Transcript
Operator: Greetings. And welcome to the BioAtla First Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
BioAtla, Inc. (NASDAQ:BCAB) Q4 2022 Earnings Call Transcript
Operator: Greetings. And welcome to the BioAtla Fourth Quarter and Full Year 2022 Earnings Conference Call. At this time, all participants are in a listen only mode.
Australian Billionaire Kerr Neilson is Selling These 15 Stocks
In this article, we discuss the 15 stocks Australian billionaire Kerr Neilson is selling.
Billionaire Hedge Funds
